Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(2 sites)
China
Shanghai Chest Hospital, Shanghai The Second Affiliated Hospital of Air Force Medical University of the People's Liberation Army of China, Xi'an